Detailed information about properties
Clomide has the active substance clomiphene citrate. It is a synthetic estrogen, close in structure to chlorotrianizene. In pharmacological action it is a blocker of estrogen receptors, like tamoxifene. It should not be confused with aromatase inhibitors (see anastrozole or letrozole).
The clomid effect is caused by selective bindings with estrogen receptors in the pituitary and ovaries. As a result, the drug stimulates the secretion of gonadotropins LH (luteinizing hormone) and FSH (follicle stimulating hormone). Subsequently, men increase testosterone synthesis.
Note: Upon completion of anabolic androgenous steroids, i.e. during post-course therapy, clomide tablets allow reducing the phenomenon of kickback and preserving the results obtained. Their main purpose in iron sports is recovery.
Clomide itself rarely provokes side effects. But it is far from being completely harmless. In particular, there is a risk of side effects on the endocrine, central nervous and digestive systems:
- Sweating, polyuria and pollugiuria;
- Dizziness, headache, insomnia;
- Meteorism, nausea or vomiting.
The drug also has a toxic effect on the liver (weak), so it is better not to abuse the dose, frequency or duration of intake.
Instructions for use Clomed
In order to recover, Clomide requires systematic intake. Working doses for male athletes range from 50 to 150 mg (1-3 tablets) per day. And the optimal amount of the drug is always selected individually. At a minimum, it is necessary to take into account the tolerability of the active ingredient by the body and the peculiarities of the AAS course. The average duration of post-course therapy is 3 weeks.
Before taking Clomide, be sure to exclude any contraindications:
- Women - uterine bleeding, ovarian cysts, pregnancy and lactation.
- Both sexes - liver failure, vision disorders, pituitary hypophysis, tumors, hypersensitivity to clomiphene citrate.
Like analogs under other trade names, Clomed (50 mg/tab, 20tab; Balkan Pharmaceuticals) is carefully assigned to patients whose work activity depends on the ability to concentrate attention and the speed of psychomotor reactions.